Elizabeth A. Lyle

2.3k total citations
24 papers, 1.6k citations indexed

About

Elizabeth A. Lyle is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, Elizabeth A. Lyle has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Elizabeth A. Lyle's work include Chemical Synthesis and Analysis (6 papers), Peptidase Inhibition and Analysis (6 papers) and Immune Response and Inflammation (6 papers). Elizabeth A. Lyle is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Peptidase Inhibition and Analysis (6 papers) and Immune Response and Inflammation (6 papers). Elizabeth A. Lyle collaborates with scholars based in United States, Canada and United Kingdom. Elizabeth A. Lyle's co-authors include Mary K. Hayden, Robert A. Weinstein, Donald Blom, Richard I. Tapping, Katherine Omueti Ayoade, David van de Vijver, Marc J. M. Bonten, C. Mark Johnson, Charity G. Moore and Joseph J. Lynch and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Elizabeth A. Lyle

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Lyle United States 17 578 462 300 271 235 24 1.6k
Maria Salomé Gomes Portugal 29 659 1.1× 350 0.8× 402 1.3× 145 0.5× 94 0.4× 61 2.0k
David J. Schmeling United States 22 484 0.8× 397 0.9× 370 1.2× 226 0.8× 229 1.0× 35 1.8k
J. W. Shands United States 23 168 0.3× 501 1.1× 362 1.2× 122 0.5× 148 0.6× 57 1.5k
Bruce Polsky United States 28 784 1.4× 213 0.5× 269 0.9× 57 0.2× 113 0.5× 78 2.9k
M. T. Labro France 21 205 0.4× 386 0.8× 200 0.7× 150 0.6× 218 0.9× 59 1.3k
W. Opferkuch Germany 26 200 0.3× 587 1.3× 396 1.3× 84 0.3× 173 0.7× 119 2.1k
Fulvia Pimpinelli Italy 23 310 0.5× 274 0.6× 289 1.0× 98 0.4× 48 0.2× 69 1.5k
Håkan Odeberg Sweden 15 86 0.1× 561 1.2× 365 1.2× 339 1.3× 125 0.5× 34 1.3k
Seth Hetherington United States 27 936 1.6× 438 0.9× 406 1.4× 183 0.7× 144 0.6× 60 2.6k
Shalini Shenoy India 26 281 0.5× 351 0.8× 229 0.8× 50 0.2× 51 0.2× 134 2.3k

Countries citing papers authored by Elizabeth A. Lyle

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Lyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Lyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Lyle more than expected).

Fields of papers citing papers by Elizabeth A. Lyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Lyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Lyle. The network helps show where Elizabeth A. Lyle may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Lyle

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Lyle. A scholar is included among the top collaborators of Elizabeth A. Lyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Lyle. Elizabeth A. Lyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isaacs, Richard C.A., Swati P. Mercer, Bruce D. Dorsey, et al.. (2010). P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position. Bioorganic & Medicinal Chemistry Letters. 21(5). 1532–1535. 3 indexed citations
2.
Isaacs, Richard C.A., Swati P. Mercer, Linda S. Payne, et al.. (2010). Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(5). 1536–1540. 6 indexed citations
3.
Paul, Catherine J., Elizabeth A. Lyle, Terry J. Beveridge, et al.. (2009). Characterization of the cell surface glycolipid from Spirochaeta aurantia. Glycoconjugate Journal. 26(9). 1097–1108. 3 indexed citations
4.
Johnson, C. Mark, Elizabeth A. Lyle, Katherine Omueti Ayoade, et al.. (2007). Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy. The Journal of Immunology. 178(12). 7520–7524. 211 indexed citations
5.
Hayden, Mary K., Donald Blom, Elizabeth A. Lyle, Charity G. Moore, & Robert A. Weinstein. (2007). Risk of Hand or Glove Contamination After Contact With Patients Colonized With Vancomycin-Resistant Enterococcus or the Colonized Patients' Environment. Infection Control and Hospital Epidemiology. 29(2). 149–154. 232 indexed citations
6.
Ayoade, Katherine Omueti, et al.. (2007). The Polymorphism P315L of Human Toll-Like Receptor 1 Impairs Innate Immune Sensing of Microbial Cell Wall Components. The Journal of Immunology. 178(10). 6387–6394. 77 indexed citations
7.
Hajishengallis, George, Richard I. Tapping, Evlambia Harokopakis, et al.. (2006). Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cellular Microbiology. 8(10). 1557–1570. 155 indexed citations
8.
Hayden, Mary K., Marc J. M. Bonten, Donald Blom, et al.. (2006). Reduction in Acquisition of Vancomycin-Resistant Enterococcus after Enforcement of Routine Environmental Cleaning Measures. Clinical Infectious Diseases. 42(11). 1552–1560. 291 indexed citations
9.
Ayoade, Katherine Omueti, et al.. (2005). Domain Exchange between Human Toll-like Receptors 1 and 6 Reveals a Region Required for Lipopeptide Discrimination. Journal of Biological Chemistry. 280(44). 36616–36625. 121 indexed citations
10.
Stauffer, Kenneth J., Peter Williams, Terry A. Lyle, et al.. (2004). Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 14(16). 4161–4164. 16 indexed citations
11.
Vinogradov, Evgeny, Catherine J. Paul, Jianjun Li, et al.. (2004). The structure and biological characteristics of the Spirochaeta aurantia outer membrane glycolipid LGLB. European Journal of Biochemistry. 271(23-24). 4685–4695. 6 indexed citations
12.
Sanderson, Philip E.J., Adel M. Naylor-Olsen, Franklin C. Clayton, et al.. (2003). 3-Amino-4-sulfonylpyridinone acetamide and related pyridothiadiazine thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1441–1444. 8 indexed citations
13.
Robinson, Mary Ann, et al.. (2003). Differential effects of sodium nitroprusside and hydralazine in a rat model of topical FeCl3-induced carotid artery thrombosis. Thrombosis Research. 111(1-2). 59–64. 13 indexed citations
14.
Coburn, Craig A., Peter Williams, Carl F. Homnick, et al.. (2000). Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(10). 1069–1072. 19 indexed citations
15.
Sanderson, Philip E.J., Bruce D. Dorsey, Colleen M. McDonough, et al.. (1998). L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor. Bioorganic & Medicinal Chemistry Letters. 8(7). 817–822. 51 indexed citations
16.
Isaacs, Richard C.A., Philip E.J. Sanderson, Elizabeth Baskin, et al.. (1998). C6 Modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption. Bioorganic & Medicinal Chemistry Letters. 8(13). 1719–1724. 19 indexed citations
17.
18.
Lyle, Terry A., Zhongguo Chen, Roger Freidinger, et al.. (1997). Synthesis, evaluation, and crystallographic analysis of L-371,912: A potent and selective active-site thrombin inhibitor. Bioorganic & Medicinal Chemistry Letters. 7(1). 67–72. 34 indexed citations
19.
Sanderson, Philip E.J., Adel M. Naylor-Olsen, Joseph P. Vacca, et al.. (1997). L-373,890, An achiral, noncovalent, subnanomolar thrombin inhibitor. Bioorganic & Medicinal Chemistry Letters. 7(12). 1497–1500. 32 indexed citations
20.
Lyle, Elizabeth A., Michael J. Mellott, Stephen F. Brady, et al.. (1995). Inhibition of Thrombin by Peptides Containing Lysyl-α-Keto Carbonyl Derivatives. Thrombosis and Haemostasis. 74(4). 1107–1112. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Salomé Gomes Breakdown of academic impact, for papers by David J. Schmeling Breakdown of academic impact, for papers by J. W. Shands Breakdown of academic impact, for papers by Bruce Polsky Breakdown of academic impact, for papers by M. T. Labro Breakdown of academic impact, for papers by W. Opferkuch Breakdown of academic impact, for papers by Fulvia Pimpinelli Breakdown of academic impact, for papers by Håkan Odeberg Breakdown of academic impact, for papers by Seth Hetherington Breakdown of academic impact, for papers by Shalini Shenoy
Rankless by CCL
2026